tiprankstipranks
Roivant Sciences (ROIV)
NASDAQ:ROIV

Roivant Sciences (ROIV) Financial Statements

442 Followers

Roivant Sciences Financial Overview

Roivant Sciences's market cap is currently ―. The company's EPS TTM is $5.067; its P/E ratio is 2.14; Roivant Sciences is scheduled to report earnings on August 12, 2024, and the estimated EPS forecast is $-0.24. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 28.93M$ 37.14M$ 37.10M$ 16.66M-
Gross Profit$ 24.52M$ 33.47M$ 37.10M$ 21.62M-
EBIT$ -184.28M$ 5.11B$ -318.11M$ -317.18M-
EBITDA$ -179.05M$ 5.11B$ -310.83M$ -309.72M-
Net Income Common Stockholders$ -151.12M$ 5.10B$ -262.66M$ -291.82M-
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 6.54B$ 6.67B$ 1.41B$ 1.43B$ 1.68B
Total Assets$ 7.22B$ 7.31B$ 2.07B$ 2.14B$ 2.39B
Total Debt$ 499.75M$ 506.58M$ 497.98M$ 492.63M$ 481.40M
Net Debt$ -6.04B$ -6.16B$ -910.25M$ -941.46M$ -1.20B
Total Liabilities$ 773.95M$ 728.10M$ 739.91M$ 802.51M$ 782.02M
Stockholders Equity$ 5.97B$ 6.09B$ 948.53M$ 910.73M$ 1.16B
Cash Flow-
Free Cash Flow$ -108.81M$ -210.81M$ -196.75M$ -250.29M-
Operating Cash Flow$ -108.46M$ -210.45M$ -196.47M$ -249.89M-
Investing Cash Flow$ 6.93M$ 5.23B$ -36.45M$ 105.00K-
Financing Cash Flow$ -32.62M$ 236.64M$ 207.87M$ 7.48M-
Currency in USD

Roivant Sciences Earnings and Revenue History

Roivant Sciences Debt to Assets

Roivant Sciences Cash Flow

Roivant Sciences Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis